TransMedics (TMDX) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.92% |
| Dec 31, 2025 | -50.39% |
| Sep 30, 2025 | -24.05% |
| Jun 30, 2025 | 3,308.72% |
| Mar 31, 2025 | -114.52% |
| Dec 31, 2024 | 186.76% |
| Sep 30, 2024 | -73.34% |
| Jun 30, 2024 | 848.70% |
| Mar 31, 2024 | -141.37% |
| Dec 31, 2023 | 220.91% |
| Sep 30, 2023 | -18.35% |
| Jun 30, 2023 | 33.00% |
| Mar 31, 2023 | -114.65% |
| Dec 31, 2022 | 71.75% |
| Sep 30, 2022 | -57.05% |
| Jun 30, 2022 | 50.59% |
| Mar 31, 2022 | -176.87% |
| Dec 31, 2021 | 28.90% |
| Sep 30, 2021 | -68.89% |
| Jun 30, 2021 | 24.47% |
| Mar 31, 2021 | -2.69% |
| Dec 31, 2020 | -11.32% |
| Sep 30, 2020 | 24.91% |
| Jun 30, 2020 | -4.44% |
| Mar 31, 2020 | -12.56% |
| Dec 28, 2019 | -29.78% |
| Sep 28, 2019 | 53.97% |
| Jun 29, 2019 | -67.34% |
| Mar 30, 2019 | -18.73% |
| Dec 29, 2018 | -0.92% |
| Sep 29, 2018 | 18.81% |
| Jun 30, 2018 | -17.98% |